Asunercept [1450882-18-4]

TargetMol Chemicals

Asunercept

9

1450882-18-4

Antibody

Research Use Only

Asunercept

Asunercept (APG101; CAN008), a soluble CD95-Fc fusion protein, selectively targets and binds to CD95L, effectively disrupting CD95/CD95L signaling. It is utilized in research for treating glioblastoma multiforme (GBM), myelodysplastic syndrome (MDS), and graft-versus-host disease (GvHD) [1] [2] [3].

3 years

-20°C

12352203